drugset / Trial / NCT00306540

Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress Disorder

NCT00306540

Phase 3 Completed 90 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate how effective quetiapine versus placebo is when added to an existing therapy, in reducing the symptoms of PTSD.

Timeline

Start
2004-12
Primary completion
2007-09
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule Oral